Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to ...

Google is revising its diversity, equity, and inclusion initiatives, dropping its previous goals for increasing hires from ...

The National Endowment for the Arts canceled one initiative and said another would prioritize projects about the Declaration ...

Global equity plans are complex, and administration requires collaboration between various departments, including legal, ...

The primary development in executive compensation disclosure for the 2025 proxy season is new Item 402(x) under Regulation ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

U.S. President Donald Trump's administration will take steps to defund the federal Education Department, a White House ...

X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, ...